NCT00066378View on ClinicalTrials.gov

Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

August 31, 2007

Conditions

Breast Cancer

Interventions

DRUG

anastrozole

DRUG

gefitinib

Trial Locations (9)

1000

Institut Jules Bordet, Brussels

2610

Algemeen Ziekenhuis Sint-Augustinus, Wilrijk

33076

Institut Bergonie, Bordeaux

76038

Centre Henri Becquerel, Rouen

B-2020

Ziekenhuis Netwerk Antwerpen Middelheim, Antwerp

1066 CX

Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam

NL-6500 HB

Universitair Medisch Centrum St. Radboud - Nijmegen, Nijmegen

Sl-1000

Institute of Oncology - Ljubljana, Ljubljana

EH4 2XU

Edinburgh Cancer Centre at Western General Hospital, Edinburgh

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00066378 - Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer | Biotech Hunter | Biotech Hunter